Delivery Order SPE2DB22D2206-SPE2DB25FKA36
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,896.41 to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120 count) on August 29, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $8,896.41 delivery order to AmerisourceBergen Drug Corp for Tafinlar 75 mg capsules (120 count) on July 17, 2025, with an ultimate completion date of August 7, 2025. This firm fixed price delivery order, issued without set-aside designation, was competitively awarded and performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single shipment of this oncology medication through AmerisourceBergen's established federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract. The award, valued at $17,792.82, is set to be completed by September 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 50 mg capsules (120 count) at a firm fixed price of $13,836.26. This is a non-set-aside contract with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,836.26 to AmerisourceBergen Drug Corp for the supply of Tafinlar 50 mg capsules (120 count) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) with a ceiling value of $13,836.26. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded, non-set-aside contract with no small business preferences applied. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 120 capsules of Tafinlar 75 mg, a chemotherapy medication, under a firm fixed-price contract valued at $54,926.66. The contract was competitively awarded without set-aside provisions and is scheduled for completion by October 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tafinlar 75 mg capsules (120 count) valued at $8,896.41, with an ultimate completion date of September 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp was awarded a $13,836.26 delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of TAFINLAR 50 mg capsules (120-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by October 6, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $8,896.41 firm fixed-price delivery order on May 6, 2025, for the supply of Tafinlar 75 mg capsules (120-count units), with an ultimate completion date of May 28, 2025. This non-set-aside contract was competitively awarded and reflects AmerisourceBergen's established role as a critical pharmaceutical supplier to the federal government. The product will be delivered to the company's corporate office location in Conshohocken,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKA36Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,754.39 to AmerisourceBergen Drug Corp for the supply of Tafinlar 50 mg capsules (120 count) on September 22, 2025, with completion scheduled for October 14, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric pharmaceutical product delivery under a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is the place of performance for this order. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply diverse pharmaceutical products and medical commodities to support military healthcare programs worldwide. The award demonstrates AmerisourceBergen Drug Corp's established capability to fulfill federal medical supply requirements through open competition, as evidenced by its extensive portfolio of pharmaceutical deliveries to defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.8k | 9/22/25 |